Showing 1 posts of 1 posts found.
The UK medicine regulatory authority has suspended the licence for a levothyroxine product sold by Teva on the grounds that …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO